Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for chronic cough due to reflux
2004-004748-27Phase 3Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastroesophageal reflux disease (GERD) and chronic cough comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Change in cough index. Started Feb 2005; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)chronic cough
Beyond the preview
Go deeper on 2004-004748-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004748-27.